SCHEMBL13995125

SCHEMBL13995125

C[Si](C)(C)c1ccc2c(-c3ccc4ccccc4c3)c3cc([Si](C)(C)C)ccc3c(-c3ccc(-c4ccc5ccccc5c4)cc3)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 4/20 0.42
▸ ESR2 Q92731 4/20 0.42
▸ LPL P06858 1/20 0.40
▸ LIPG Q9Y5X9 1/20 0.40
▸ IKBKB O14920 1/20 0.39
▸ CYP11B1 P15538 2/20 0.38
▸ CYP11B2 P19099 2/20 0.38
▸ CYP17A1 P05093 1/20 0.38
▸ CYP19A1 P11511 1/20 0.38
▸ CYP1A2 P05177 4/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ ALOX5 P09917 1/20 0.38
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17935586 0.95 ESR1 (0.42) ESR1ESR2LPLLIPGCYP11B1
SCHEMBL125734 0.95 CYP1A2 (0.41) ESR1ESR2LPLLIPGIKBKB
SCHEMBL16352621 0.95 IKBKB (0.42) ESR1ESR2LPLLIPGIKBKB
SCHEMBL126430 0.94 ESR1 (0.42) ESR1ESR2LPLLIPGIKBKB
SCHEMBL16352617 0.94 CYP1A2 (0.42) ESR1ESR2IKBKBCYP11B1CYP11B2
SCHEMBL16352618 0.94 IKBKB (0.41) ESR1ESR2LPLLIPGIKBKB
SCHEMBL23027127 0.93 ESR1 (0.39) ESR1ESR2LPLLIPGIKBKB
SCHEMBL13007010 0.93 ESR1 (0.41) ESR1ESR2LPLLIPGIKBKB
SCHEMBL16352623 0.93 ESR1 (0.43) ESR1ESR2IKBKBCYP11B1CYP11B2
SCHEMBL125705 0.92 ESR1 (0.43) ESR1ESR2LPLLIPGIKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8795847-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2014-08-05 — — US disclosed
US-20080303003-A1 Novel Materials for Organic Electroluminescent Devices MERCK PATENT GMBH (DE) 2008-12-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080303003-A1 Novel Materials for Organic Electroluminescent Devices ANXA2, ANXA3, ANXA1 ESR1 516/4885ESR2 1070/4885LPL 3133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback